AET

7 Best Healthcare ETFs for 2018

The best healthcare ETFs for 2018 offer growth and stability. These funds show healthcare investing is both low risk and high reward.

Aetna (AET) a Strong Buy on Top-End Quant Score

Aetna Inc (NYSE:AET) is a $59.6 billion in market value constituent of the Health Care Providers & Services GICS industry group where the stock's Portfolio Grader ranking places it 10 among the 81 companies in this industry group, putting in the top quartile. AET is ranked among the sector leaders with a ranking of 69 among the 782 companies in the sector and number 421 in the 5000 company Portfolio Grader company universe.

Top-End Analytics for Earnings Visibility Keep Aetna (AET) a Strong Buy

Currently, Aetna Inc (NYSE:AET) has a Strong Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. The current Portfolio Grader recommendation on the shares has been in place for the last month.

CVS Health Corp’s Aetna Inc Acquisition Is Smart Vertical Integration

CVS gives Aetna visibility into its costs. CVS' Pharmacy Benefit Manager and Minute Clinics are real health care cost control.

3 Stocks to Watch on Monday: Aetna Inc (AET), Alphabet Inc (GOOG, GOOGL) and Sony Corp (ADR) (SNE)

Aetna (AET) will be acquired by CVS, Alphabet (GOOGL) offers Pixelbook-Netflix deal and Sony's (SNE) PlayStation VR trial is a hit.

Aetna (AET) a Strong Buy on Outstanding Quant Score

The current recommendation of Strong Buy for Aetna Inc (NYSE:AET) is the result of using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. AET has recently seen its Portfolio Grader rating upgraded from a Buy to a Strong Buy.

Stellar Metrics for Earnings Growth Keep Aetna (AET) a Strong Buy

Portfolio Grader currently ranks Aetna Inc (NYSE:AET) a Strong Buy. With proprietary fundamental and quantitative metrics developed by Louis Navellier, this analytical tool researches nearly 5,000 stocks weekly. AET has recently seen its Portfolio Grader rating upgraded from a Buy to a Strong Buy.

Exceptional Earnings Growth Analytics Drive Upgrade of Aetna (AET) to Strong Buy

The current recommendation of Strong Buy for Aetna Inc (NYSE:AET) is the result of using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. AET has been upgraded from a Buy to a Strong Buy in the last week.

Trade of the Day: Aetna Inc (AET)

The potential takeover of Aetna would make CVS more like a medical center at the same time as it’s operating its drug stores.

Stock of Aetna (AET) Upgraded to Strong Buy From a Buy

The current recommendation of Strong Buy for Aetna Inc (NYSE:AET) has been derived by using the methods for investing of Louis Navellier and his Portfolio Grader stock evaluator. AET has been upgraded from a Buy to a Strong Buy in the last week.

Aetna (AET) a Buy on Solid Earnings Growth

As one of the 783 companies in the GICS Health Care sector Aetna Inc (NYSE:AET) is a constituent of the 82 company Health Care Providers & Services GICS industry group within this sector. AET has a market value of $57.5 billion which is in the top decile in its industry group. Portfolio Grader's current ranking for AET puts it 12 among the 82 companies in this industry group, putting in the top quartile; among the sector leaders with a ranking of 68 among the 783 companies in the sector, and number 469 in the nearly 5,000 company Portfolio Grader universe.

Pfizer Inc. Stock Is Boring, and That’s Perfect

Pfizer has been a boring stock for years. Which makes PFE stock perfect to sell downside risk against unlikely scenarios.

3 Key Earnings Reports to Watch Next Week

Investors will want to hear more about CVS/AET rumor, PFE looks to have a strong showing and UAA need to keep up with competition.

Why You Should Care About a CVS Health Corp Buyout of Aetna Inc

CVS and Aetna will be able to link healthcare income to healthcare outgo, which would be a big win for CVS stock owners.

Aetna (AET) a Buy on Solid Quant Score

Portfolio Grader currently ranks Aetna Inc (NYSE:AET) a Buy. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. AET has maintained this ranking for the last month.

Earnings Visibility Keeps Aetna (AET) a Buy

Aetna Inc (NYSE:AET) is ranked as a Buy using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking AET has had from Portfolio Grader for the last month.

Aetna (AET) Shares Raised to Strong Buy from a Buy

The current recommendation of Strong Buy for Aetna Inc (NYSE:AET) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Aetna (AET) Shares Raised to Strong Buy from a Buy

The current recommendation of Strong Buy for Aetna Inc (NYSE:AET) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

3 Big Stock Charts for Tuesday: Abbott Laboratories (ABT), Aetna Inc (AET) and Boston Scientific Corporation (BSX)

Abbott Laboratories (ABT), Aetna (AET) and Boston Scientific (BSX) all made bullish moves above their top bollinger bands on Monday.